Filter News
Area of Research
News Topics
- (-) Biomedical (48)
- 3-D Printing/Advanced Manufacturing (104)
- Advanced Reactors (30)
- Artificial Intelligence (59)
- Big Data (40)
- Bioenergy (75)
- Biology (81)
- Biotechnology (15)
- Buildings (40)
- Chemical Sciences (41)
- Clean Water (25)
- Climate Change (65)
- Composites (18)
- Computer Science (157)
- Coronavirus (46)
- Critical Materials (19)
- Cybersecurity (34)
- Decarbonization (48)
- Element Discovery (1)
- Energy Storage (93)
- Environment (165)
- Exascale Computing (26)
- Fossil Energy (2)
- Frontier (28)
- Fusion (45)
- Grid (51)
- High-Performance Computing (57)
- Hydropower (11)
- Irradiation (2)
- Isotopes (38)
- ITER (6)
- Machine Learning (36)
- Materials (113)
- Materials Science (117)
- Mathematics (5)
- Mercury (12)
- Microelectronics (1)
- Microscopy (49)
- Molten Salt (7)
- Nanotechnology (58)
- National Security (39)
- Net Zero (5)
- Neutron Science (113)
- Nuclear Energy (90)
- Partnerships (22)
- Physics (55)
- Polymers (28)
- Quantum Computing (21)
- Quantum Science (53)
- Renewable Energy (2)
- Security (22)
- Simulation (22)
- Software (1)
- Space Exploration (20)
- Statistics (1)
- Summit (50)
- Sustainable Energy (106)
- Transformational Challenge Reactor (7)
- Transportation (76)
Media Contacts

OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.

As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.

OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
![Coexpression_hi-res_image[1].jpg Coexpression_hi-res_image[1].jpg](/sites/default/files/styles/list_page_thumbnail/public/Coexpression_hi-res_image%5B1%5D_0.jpg?itok=OnLe-krT)
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
![2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg 2018-P07635 BL-6 user - Univ of Guelph-6004R_sm[2].jpg](/sites/default/files/styles/list_page_thumbnail/public/2018-P07635%20BL-6%20user%20-%20Univ%20of%20Guelph-6004R_sm%5B2%5D.jpg?itok=DUdZNt_q)
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.

The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...

A novel method developed at Oak Ridge National Laboratory creates supertough renewable plastic with improved manufacturability. Working with polylactic acid, a biobased plastic often used in packaging, textiles, biomedical implants and 3D printing, the research team added tiny amo...